Rapid Micro Biosystems (RPID) FCF Margin (2020 - 2026)
Rapid Micro Biosystems recorded quarterly FCF Margin of 193.1% in Q1 2026, down 440.32% quarter-over-quarter from 35.74% in Q4 2025, and down 6286.0% year-over-year from 3.12% in Q1 2025.
Rapid Micro Biosystems' FCF Margin history runs 7 years deep, the most recent figure standing at 193.1% for Q1 2026.
- In Q1 2026, FCF Margin fell 6286.0% year-over-year to 193.1%; the TTM figure through Mar 2026 stood at 110.46% (up 2040.0% YoY), while the FY2025 annual figure was 95.01%, up 6726.0% from the prior year.
- FCF Margin came in at 193.1% for Q1 2026 at Rapid Micro Biosystems, down from 35.74% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 35.74% in Q4 2025 to a low of 440.0% in Q1 2022.
- A 5-year average of 205.91% and a median of 153.64% in 2023 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin plunged 20951 bps in 2022 and surged 29038 bps in 2023, its largest moves.
- Rapid Micro Biosystems' FCF Margin stood at 143.74% in 2022, then retreated by 7 bps to 153.64% in 2023, then increased by 11 bps to 136.85% in 2024, then soared by 74 bps to 35.74% in 2025, then slumped by 440 bps to 193.1% in 2026.
- According to Business Quant data, FCF Margin over the past three periods registered 193.1%, 35.74%, and 115.34% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 25.51% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -1.28% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.68% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 37.67% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.98% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 15.44% |
| 10 | Rapid Micro Biosystems | 89.50 Mn | 66.56 Mn | 371,000.00 | -193.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -193.10% |
| Dec 31, 2025 | -29.59% |
| Sep 30, 2025 | -124.19% |
| Jun 30, 2025 | -130.21% |
| Mar 31, 2025 | -130.24% |
| Dec 31, 2024 | -124.00% |
| Sep 30, 2024 | -99.74% |
| Jun 30, 2024 | -159.84% |
| Mar 31, 2024 | -287.11% |
| Dec 31, 2023 | -156.46% |
| Sep 30, 2023 | -165.35% |
| Jun 30, 2023 | -188.02% |
| Mar 31, 2023 | -346.47% |
| Dec 31, 2022 | -420.30% |
| Sep 30, 2022 | -227.35% |
| Jun 30, 2022 | -439.77% |
| Mar 31, 2022 | -460.43% |
| Dec 31, 2021 | -285.20% |
| Sep 30, 2021 | -286.53% |
| Jun 30, 2021 | -196.53% |
| Mar 31, 2021 | -230.49% |
| Dec 31, 2020 | -103.78% |
| Sep 30, 2020 | -160.83% |